Suppr超能文献

高血糖和正常血糖高胰岛素血糖钳夹研究中持续葡萄糖监测和床边人工胰腺葡萄糖测量的准确性和时间延迟

Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.

作者信息

Kuroda Akio, Taniguchi Satoshi, Akehi Yuko, Mori Hiroyasu, Tamaki Motoyuki, Suzuki Reiko, Otsuka Yinhua, Matsuhisa Munehide

机构信息

1 Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.

出版信息

J Diabetes Sci Technol. 2017 Nov;11(6):1096-1100. doi: 10.1177/1932296817735122. Epub 2017 Oct 9.

Abstract

BACKGROUND

Glucose values of continuous glucose monitoring (CGM) have time delays compared with plasma glucose (PG) values. The artificial pancreas (STG-55, Nikkiso, Japan) (AP), which measures venous blood glucose directly, also has a time delay because of the long tubing lines from sampling vessel to the glucose sensor. We investigate accuracy and time delay of CGM and AP in comparison with PG values during 2-step glucose clamp study.

METHODS

Seven patients with type 2 diabetes and 2 healthy volunteers were included in this study. CGM (Enlite sensor, Medtronic, Northridge, CA, USA) was attached on the day before the experiment. Hyperglycemic (200 mg/dL) clamp was performed for 90 minutes, followed by euglycemic (100 mg/dL) hyperinsulinemic (100 μU/mL) clamp for 90-120 minutes using AP. CGM sensor glucose was calibrated just before and after the clamp study. AP and CGM values were compared with PG values.

RESULTS

AP values were significantly lower than PG values at 5, 30 minute during hyperglycemic clamp. In comparison, CGM value at 0 minute was significantly higher, and its following values were almost significantly lower than PG values. The time delay of AP and CGM values to reach maximum glucose levels were 5.0 ± 22.3 (NS) and 28.6 ± 32.5 ( P < .05) min, respectively. Mean absolute rate difference of CGM was significantly higher than AP (24.0 ± 7.6 vs 15.3 ± 4.6, P < .05) during glucose rising period (0-45 min); however, there were no significant differences during other periods.

CONCLUSIONS

Both CGM and AP failed to follow plasma glucose values during nonphysiologically rapid glucose rising, but indicated accurate values during physiological glucose change.

摘要

背景

连续血糖监测(CGM)的血糖值与血浆葡萄糖(PG)值相比存在时间延迟。直接测量静脉血糖的人工胰腺(STG - 55,日本日机装公司)(AP),由于从采样容器到葡萄糖传感器的管路较长,也存在时间延迟。我们在两步葡萄糖钳夹研究中,比较CGM和AP与PG值的准确性和时间延迟。

方法

本研究纳入7例2型糖尿病患者和2名健康志愿者。实验前一天佩戴CGM(美国美敦力公司,加利福尼亚州北岭,Enlite传感器)。进行90分钟的高血糖(200 mg/dL)钳夹,随后使用AP进行90 - 120分钟的正常血糖(100 mg/dL)高胰岛素血症(100 μU/mL)钳夹。在钳夹研究前后对CGM传感器葡萄糖进行校准。将AP和CGM值与PG值进行比较。

结果

在高血糖钳夹期间的5分钟、30分钟时,AP值显著低于PG值。相比之下,CGM在0分钟时的值显著更高,其随后的值几乎均显著低于PG值。AP和CGM值达到最大血糖水平的时间延迟分别为5.0±22.3(无统计学意义)和28.6±32.5(P<.05)分钟。在血糖上升期(0 - 45分钟),CGM的平均绝对变化率显著高于AP(24.0±7.6对15.3±4.6,P<.05);然而,在其他时间段无显著差异。

结论

在非生理性快速血糖上升期间,CGM和AP均未能跟踪血浆葡萄糖值,但在生理性血糖变化期间显示出准确的值。

相似文献

2
A Comparison of Time Delay in Three Continuous Glucose Monitors for Adolescents and Adults.
J Diabetes Sci Technol. 2017 Nov;11(6):1132-1137. doi: 10.1177/1932296817704443. Epub 2017 May 1.
3
Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
Diabetes Technol Ther. 2012 Jul;14(7):583-8. doi: 10.1089/dia.2011.0271. Epub 2012 Apr 18.
4
Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.
J Diabetes Sci Technol. 2020 Nov;14(6):1074-1078. doi: 10.1177/1932296819848721. Epub 2019 May 16.
5
Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
J Diabetes Sci Technol. 2017 Nov;11(6):1089-1095. doi: 10.1177/1932296817714272. Epub 2017 Jun 21.
10
Evaluation of a Predictive Low-Glucose Management System In-Clinic.
Diabetes Technol Ther. 2017 May;19(5):288-292. doi: 10.1089/dia.2016.0319. Epub 2017 Feb 16.

引用本文的文献

1
Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the United States.
Front Endocrinol (Lausanne). 2024 Jul 1;15:1403858. doi: 10.3389/fendo.2024.1403858. eCollection 2024.
2
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.
J Diabetes Sci Technol. 2023 Nov;17(6):1506-1526. doi: 10.1177/19322968231190941. Epub 2023 Aug 20.
3
Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao, China.
Front Endocrinol (Lausanne). 2022 Oct 6;13:1001844. doi: 10.3389/fendo.2022.1001844. eCollection 2022.
5
Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care.
SAGE Open Med. 2020 Nov 19;8:2050312120974174. doi: 10.1177/2050312120974174. eCollection 2020.
6
8
Categorization of β-cell capacity in patients with obesity via OGTT using K-means clustering.
Endocr Connect. 2020 Feb;9(2):135-143. doi: 10.1530/EC-19-0476.
9
Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.
J Diabetes Sci Technol. 2020 Nov;14(6):1074-1078. doi: 10.1177/1932296819848721. Epub 2019 May 16.

本文引用的文献

1
Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit.
J Artif Organs. 2016 Jun;19(2):159-66. doi: 10.1007/s10047-015-0877-2. Epub 2015 Dec 31.
2
Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures.
J Diabetes Sci Technol. 2015 Aug 4;9(5):1006-15. doi: 10.1177/1932296815590154.
3
Impact of newly developed, next-generation artificial endocrine pancreas.
J Med Invest. 2015;62(1-2):41-4. doi: 10.2152/jmi.62.41.
4
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor.
Diabetes Technol Ther. 2014 May;16(5):277-83. doi: 10.1089/dia.2013.0222. Epub 2014 Apr 7.
6
Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm.
J Diabetes Sci Technol. 2012 Mar 1;6(2):475-6. doi: 10.1177/193229681200600237.
8
Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.
J Diabetes Sci Technol. 2009 Sep 1;3(5):1207-14. doi: 10.1177/193229680900300528.
9
Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
Diabetes Res Clin Pract. 2005 Jul;69(1):1-4. doi: 10.1016/j.diabres.2004.10.006. Epub 2004 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验